Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Association of Alzheimer's disease GWAS loci with MRI markers of brain aging.

Neurobiology of aging | 2015

Whether novel risk variants of Alzheimer's disease (AD) identified through genome-wide association studies also influence magnetic resonance imaging-based intermediate phenotypes of AD in the general population is unclear. We studied association of 24 AD risk loci with intracranial volume, total brain volume, hippocampal volume (HV), white matter hyperintensity burden, and brain infarcts in a meta-analysis of genetic association studies from large population-based samples (N = 8175-11,550). In single-SNP based tests, AD risk allele of APOE (rs2075650) was associated with smaller HV (p = 0.0054) and CD33 (rs3865444) with smaller intracranial volume (p = 0.0058). In gene-based tests, there was associations of HLA-DRB1 with total brain volume (p = 0.0006) and BIN1 with HV (p = 0.00089). A weighted AD genetic risk score was associated with smaller HV (beta ± SE = -0.047 ± 0.013, p = 0.00041), even after excluding the APOE locus (p = 0.029). However, only association of AD genetic risk score with HV, including APOE, was significant after multiple testing correction (including number of independent phenotypes tested). These results suggest that novel AD genetic risk variants may contribute to structural brain aging in nondemented older community persons.

Pubmed ID: 25670335 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NHLBI NIH HHS, United States
    Id: HHSN268201100012C
  • Agency: NCRR NIH HHS, United States
    Id: UL1RR025005
  • Agency: NHLBI NIH HHS, United States
    Id: N01-HC-25195
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL103612
  • Agency: NHLBI NIH HHS, United States
    Id: HHSN268201100009I
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS017950
  • Agency: NIA NIH HHS, United States
    Id: N01AG12100
  • Agency: NIA NIH HHS, United States
    Id: RF1 AG015819
  • Agency: NHLBI NIH HHS, United States
    Id: R01HL7825
  • Agency: NHLBI NIH HHS, United States
    Id: R01HL59367
  • Agency: NHLBI NIH HHS, United States
    Id: HHSN268201100010C
  • Agency: NCRR NIH HHS, United States
    Id: UL1 RR025005
  • Agency: NIA NIH HHS, United States
    Id: R01 AG015928
  • Agency: NHLBI NIH HHS, United States
    Id: HHSN268201100008C
  • Agency: NHLBI NIH HHS, United States
    Id: U01 HL080295
  • Agency: NHLBI NIH HHS, United States
    Id: HHSN268201100005G
  • Agency: Intramural NIH HHS, United States
    Id: Z01 AG007270-08
  • Agency: NHLBI NIH HHS, United States
    Id: HHSN268201100008I
  • Agency: NIA NIH HHS, United States
    Id: P30AG0101029
  • Agency: PHS HHS, United States
    Id: HHSN268201100005C
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL059367
  • Agency: NHLBI NIH HHS, United States
    Id: HHSN268201100007C
  • Agency: NIA NIH HHS, United States
    Id: R01 AG042292
  • Agency: NHLBI NIH HHS, United States
    Id: HHSN268200800007C
  • Agency: NHLBI NIH HHS, United States
    Id: N01 HC015103
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS17950
  • Agency: PHS HHS, United States
    Id: HHSN268201100009C
  • Agency: Intramural NIH HHS, United States
    Id: Z01 AG007380-02
  • Agency: NHLBI NIH HHS, United States
    Id: HHSN268201100011I
  • Agency: NHLBI NIH HHS, United States
    Id: HHSN268201100011C
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL086694
  • Agency: NIMHD NIH HHS, United States
    Id: P20 MD006886
  • Agency: NIA NIH HHS, United States
    Id: R01 AG017917
  • Agency: NIA NIH HHS, United States
    Id: AG033193
  • Agency: NIA NIH HHS, United States
    Id: R01AG17917
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL087652
  • Agency: PHS HHS, United States
    Id: HHSN268200625226C
  • Agency: NHGRI NIH HHS, United States
    Id: U01 HG004402
  • Agency: NHLBI NIH HHS, United States
    Id: HL093029
  • Agency: NCATS NIH HHS, United States
    Id: UL1 TR000124
  • Agency: NHLBI NIH HHS, United States
    Id: N01HC55222
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL093029
  • Agency: PHS HHS, United States
    Id: HHSN268201100010C
  • Agency: NHLBI NIH HHS, United States
    Id: N01HC85086
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL105756
  • Agency: NHGRI NIH HHS, United States
    Id: U01HG004402
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK063491
  • Agency: NHLBI NIH HHS, United States
    Id: HHSN268201100006C
  • Agency: NIA NIH HHS, United States
    Id: R01 AG008122
  • Agency: NHLBI NIH HHS, United States
    Id: HHSN268201200036C
  • Agency: NIA NIH HHS, United States
    Id: P30 AG010161
  • Agency: PHS HHS, United States
    Id: HHSN268201100008C
  • Agency: PHS HHS, United States
    Id: HHSN268201100012C
  • Agency: NIA NIH HHS, United States
    Id: R01 AG033193
  • Agency: NHLBI NIH HHS, United States
    Id: R01HL087641
  • Agency: NINDS NIH HHS, United States
    Id: R21 NS076827
  • Agency: NHLBI NIH HHS, United States
    Id: HHSN268201100005I
  • Agency: NHLBI NIH HHS, United States
    Id: R01HL105756
  • Agency: NIA NIH HHS, United States
    Id: R01 AG08122
  • Agency: NIA NIH HHS, United States
    Id: P50 AG005133
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL080295
  • Agency: NIA NIH HHS, United States
    Id: R01AG15819
  • Agency: PHS HHS, United States
    Id: HHSN268201100007C
  • Agency: NIA NIH HHS, United States
    Id: R01 AG020098
  • Agency: PHS HHS, United States
    Id: HHSN268200800007C
  • Agency: NHLBI NIH HHS, United States
    Id: R01HL087652
  • Agency: NHLBI NIH HHS, United States
    Id: N01HC85082
  • Agency: NHLBI NIH HHS, United States
    Id: HHSN268201100009C
  • Agency: PHS HHS, United States
    Id: HHSN268201100011C
  • Agency: NHLBI NIH HHS, United States
    Id: N01HC85083
  • Agency: NHLBI NIH HHS, United States
    Id: HHSN268201100005C
  • Agency: NHLBI NIH HHS, United States
    Id: N01HC25195
  • Agency: NIA NIH HHS, United States
    Id: P30AG10161
  • Agency: NHLBI NIH HHS, United States
    Id: HHSN268201100007I
  • Agency: NHLBI NIH HHS, United States
    Id: T32 HL007825
  • Agency: NHLBI NIH HHS, United States
    Id: N01HC15103
  • Agency: PHS HHS, United States
    Id: HHSN268201200036C
  • Agency: NIA NIH HHS, United States
    Id: P30 AG010129
  • Agency: NHLBI NIH HHS, United States
    Id: U01HL080295
  • Agency: NIA NIH HHS, United States
    Id: R01 AG040039
  • Agency: NHLBI NIH HHS, United States
    Id: R01HL103612
  • Agency: NHLBI NIH HHS, United States
    Id: N01HC85079
  • Agency: PHS HHS, United States
    Id: HHSN268201100006C
  • Agency: NIA NIH HHS, United States
    Id: R01 AG023629
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL087641
  • Agency: NHLBI NIH HHS, United States
    Id: N01HC85080
  • Agency: NIA NIH HHS, United States
    Id: R01 AG015819
  • Agency: NHLBI NIH HHS, United States
    Id: N01HC85081
  • Agency: NHLBI NIH HHS, United States
    Id: R01HL086694
  • Agency: NIA NIH HHS, United States
    Id: U01 AG049505

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


AlzGene: Field Synopsis of Genetic Association Studies in AD (tool)

RRID:SCR_006749

The AlzGene database provides a comprehensive, unbiased and regularly updated field synopsis of genetic association studies performed in Alzheimer''s disease. In addition, hundreds of up-to-date meta-analyses are available for all eligible polymorphisms with sufficient data. In addition to identifying the epsilon4 allele of APOE and related effects, we pinpointed over a dozen potential Alzheimer disease susceptibility genes (ACE, CHRNB2, CST3, ESR1, GAPDHS, IDE, MTHFR, NCSTN, PRNP, PSEN1, TF, TFAM and TNF) with statistically significant allelic summary odds ratios (ranging from 1.11-1.38 for risk alleles and 0.92-0.67 for protective alleles). Our database provides a powerful tool for deciphering the genetics of Alzheimer disease, and it serves as a potential model for tracking the most viable gene candidates in other genetically complex diseases.

View all literature mentions